Document is current
Any future updates will be listed below
-
Authors
,
Royer, Guilhem
Darty, Mélanie Mercier
Clermont, Olivier
Condamine, Bénédicte
Laouenan, Cédric
Decousser, Jean-Winoc
Vallenet, David
Lefort, Agnès
de Lastours, Victoire
Denamur, Erick
-
Funding
Funding for this research was provided by:
Agence nationale de la recherche (ANR-15-CE-17-0019-01)
Fondation médicale pour la recherche (DEQ20161136698)
Poste accueil APHP - CEA
- License Information
-
More Information
Article History
Received: 6 November 2020
Accepted: 22 April 2021
First Online: 5 May 2021
Declarations
:
: Both multicenter clinical trials were approved by ethic committees. The COLIBAFI study was approved by the French Comité de Protection des Personnes of Hôpital Saint-Louis, Paris, France (approval #2004-06, June 2004). The Septicoli study was approved by the French Comité de Protection des Personnes Ile de France n°IV (IRB 00003835, March 2016). The study was registered on clinical trials in September 2016 (ClinicalTrials.gov Identifier: NCT02890901). Because of their non-interventional nature, only an oral consent from patients was requested under French law. Both studies conformed to the principles of the Helsinki declaration.
: Not applicable.
: The authors declare that they have no competing interests.
